Q/C TECHNOLOGIES, INC. — Director's Dealing 2020

Jan 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2020-01-01

Reporting Person: Schreiber Christopher C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-01	Common Stock	M	5201	—	Acquired	5201	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-01	Restricted Stock Units	$	M	5201	Acquired		Common Stock (5201)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company").

F2: On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020.